Entera Bio Ltd. (ENTX) Financials
ENTX Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-09-30 | 8.6 million | 2.3 million |
| 2023-06-30 | 10.4 million | 2.2 million |
| 2023-03-31 | 11.6 million | 1.5 million |
| 2022-12-31 | 13.1 million | 1.4 million |
ENTX Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-09-30 | -1.5 million | 383000 |
| 2023-06-30 | -1.6 million | 472000 |
| 2023-03-31 | -1.6 million | 516000 |
| 2022-12-31 | -2.0 million | 477000 |
ENTX Net Income
No data available :(
ENTX Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-09-30 | 7.6 million | - | 402000 |
| 2023-06-30 | 9.1 million | - | 456000 |
| 2023-03-31 | 10.7 million | - | 48000 |
| 2022-12-31 | 12.3 million | - | 91000 |
ENTX Shares Outstanding
ENTX Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-09-30 | 185 | 1.4 million | 1.0 million | - |
| 2023-06-30 | 1000 | 1.2 million | 1.1 million | - |
| 2023-03-31 | 11000 | 931000 | 1.3 million | - |
| 2022-12-31 | 3000 | 1.4 million | 1.7 million | - |
ENTX Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-09-30 | - | 14000 |
| 2023-06-30 | - | 15000 |
| 2023-03-31 | - | 2.2 million |
| 2022-12-31 | 14000 | 8000 |
ENTX
Price: $2.09
52 week price:
Earnings Per Share: -0.31 USD
P/E Ratio: -2.65
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 1891
Market Capitalization: 79.8 million